Bioactive Compound Library Max | 生物活性化合物库 Max | MedChemExpress (MCE)

Bioactive small molecules are important sources of lead compounds and effective tools for drug screening. Because the target of active small molecules is clear, it is conducive to the study of mechanism. In addition, due to the large structural differences between the individual active molecules, it is easier to obtain a greater variety of lead compounds. MCE integrates the Bioactive Compound Library (HY-L001) and Novel Bioactive Compound Library (HY-L111) to form the Bioactive Compound Library Max. Bioactive Compound Library Max contains novel active small molecules, molecules that have entered the clinical stage and the market, and small molecules that have been verified by cell experiments or biochemical experiments, which fundamentally expands the number of compound libraries in the library and improves the structural diversity, and is an effective tool to start drug screening and mechanism research. MCE can provide a library of 20,154 mitophagy compounds, which can be used for drug development and mechanism research in cancer, immunity, infection and other hot research fields. 更多产品详情查看：www.medchemexpress.cn/screening/bioactive-compound-library-max.html

Bioactive Compound Library Max | 生物活性化合物库 Max | MedChemExpress (MCE)信息由MedChemExpress (MCE)为您提供，如您想了解更多关于Bioactive Compound Library Max | 生物活性化合物库 Max | MedChemExpress (MCE)报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途